deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT00866749

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

Augmented Berlin-Frankfurt-Munster Therapy for Adolescents/Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Sponsor: M.D. Anderson Cancer Center

Conditions Lymphoblastic Leukemia Lymphoblastic Lymphoma
Interventions Cyclophosphamide Cytarabine Daunorubicin Doxorubicin Intrathecal Methotrexate Mercaptopurine Methotrexate PEG-asparaginase Thioguanine Vincristine
Updated 12 times since 2017 Last updated: Aug 21, 2019 Started: Sep 12, 2006 Primary completion: Jul 26, 2018 Completion: Jul 26, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lymphoblastic Leukemia and Lymphoblastic Lymphoma, this trial is completed. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 12 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jan 2018 · 11 months · monthly snapshotActive Not Recruiting~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotActive Not Recruiting~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshotActive Not Recruiting~Sep 2018 – ~Oct 2019 · 13 months · monthly snapshotCompleted~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 7 earlier versions

  1. Oct 2019 — Jan 2021 [monthly]

    Completed PHASE2

  2. Sep 2018 — Oct 2019 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Aug 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE2

  4. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE2

  5. Jan 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  6. Feb 2017 — Jan 2018 [monthly]

    Active Not Recruiting PHASE2

  7. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations